Información del producto
NBI 42902 is a drug that has been shown to inhibit the uptake of aliphatic hydrocarbons. This inhibition may be due to its ability to act as a potent antagonist of the β-receptor and/or the hydroxy derivative. NBI 42902 was found to have antitumor properties in humans, but not in animals. The drug also has an effect on endometriosis, which may be due to its inhibition of prostaglandin synthesis. NBI 42902 is orally active and binds to receptors in the body, including those for cancerous cells.
Propiedades químicas
Consulta técnica sobre: 3D-FN103814 NBI 42902
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
